Evolus, Inc. Common Stock
EOLS Real Time Price USDRecent trades of EOLS by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by EOLS's directors and management
Government lobbying spending instances
-
$35,000 Feb 01, 2021 Issue: Trade (domestic/foreign)
-
$105,000 Jan 15, 2021 Issue: Trade (domestic/foreign)
-
$70,000 Oct 20, 2020 Issue: Trade (domestic/foreign)
-
$60,000 Apr 19, 2020 Issue: Health Issues
-
$60,000 Jan 19, 2020 Issue: Health Issues
-
$90,000 Oct 19, 2019 Issue: Health Issues
-
$90,000 Jul 19, 2019 Issue: Health Issues
-
$90,000 Apr 22, 2019 Issue: Health Issues
Estimated quarterly lobbying spending
New patents grants
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of EOLS in WallStreetBets Daily Discussion
Recent insights relating to EOLS
Recent picks made for EOLS stock on CNBC
ETFs with the largest estimated holdings in EOLS
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view EOLS Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.